A new study published in the journal Thorax has revealed that Swedish clinical air flow technology developer, Airsonett's asthma device, Protexo provides a higher quality of life for asthma patients when compared to placebo.
Protexo is a temperature controlled laminar air-flow device (TLA) , which creates a downward flow of filtered air. This air then surrounds the breathing zone of the sleeping asthma patients and protects them from allergens and irritants.
The study was based on a trial carried out among 281 asthma patients aged between 7 to 70 years and living in six different countries. Around 189 patients slept with Protexo while the remaining patients used a dummy device.